文献速递真菌感染

脂质体两性霉素B与肾脏安全性:证据回顾与临床考量

Liposomal amphotericin B and renal safety: review of the evidence and clinical considerations.
PubMed 文献 · J Antimicrob Chemother · 2026-01-01

本文综述脂质体两性霉素B(LAmB)肾脏安全性证据。LAmB毒性显著低于传统脱氧胆酸两性霉素B,但肾毒性仍受关注,危险因素包括高剂量、长疗程、联用肾毒性药物及原有肾病。建议筛查、个体化风险评估、监测,并预防性静脉补液及补镁补钾,间歇给药等策略可能减少肾毒性但需进一步研究。

要点

  • LAmB肾毒性低于传统两性霉素B,但高剂量、长疗程、联用肾毒性药及原有肾病增加风险。
  • 建议用药前筛查、个体化风险评估和监测,预防性静脉补液可降低肾毒性风险。
  • 应考虑补镁补钾以降低低镁血症和低钾血症风险,间歇给药等策略需进一步研究。

核心结论

  • LAmB较传统脱氧胆酸两性霉素B毒性显著改善,但肾毒性仍是临床关注问题,需通过筛查、风险评估和监测管理。

研究设计与样本

  • 本文为综述,回顾LAmB肾脏安全性证据及临床考量。

主要发现

  • LAmB肾毒性发生率显著低于传统两性霉素B,但高剂量、长疗程、联用肾毒性药物及原有肾病是肾毒性危险因素。
  • 预防性静脉补液被推荐用于降低LAmB肾毒性风险。
  • 应考虑补镁和补钾以分别降低低镁血症和低钾血症风险。
  • 间歇给药及某些真菌感染的单剂高剂量诱导治疗可能减少肾毒性,但需进一步研究。

关键数值与推荐

  • LAmB肾毒性危险因素包括较高剂量、较长治疗持续时间、联用肾毒性药物及存在原有肾脏疾病。
  • 推荐预防性使用静脉生理盐水以降低肾毒性风险。
  • 应考虑补镁和补钾以降低低镁血症和低钾血症风险。

临床怎么用

  • 使用LAmB前应进行适当患者筛查和个体化风险评估,用药期间监测肾功能。
  • 预防性静脉补液及考虑补镁补钾可降低肾毒性及电解质紊乱风险。
  • 对特定真菌感染可考虑间歇给药或单剂高剂量诱导治疗以减少肾毒性,但需进一步研究支持。

局限性

  • 间歇给药和单剂高剂量诱导治疗减少肾毒性的策略尚需额外研究证实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Invasive fungal infections continue to represent an important cause of morbidity and mortality in severely ill and immunocompromised patients. Liposomal amphotericin B (LAmB) has a significantly improved toxicity profile versus conventional amphotericin B deoxycholate and is recommended for a wide range of medically important opportunistic fungal pathogens. Although rates are significantly lower than with older formulations, nephrotoxicity with LAmB remains a concern. Risk factors for renal toxicity with LAmB include higher doses, longer duration of treatment, concomitant use of nephrotoxic agents and the presence of pre-existing kidney disease. Appropriate patient screening, individualized risk assessment, and patient monitoring may reduce the risk of renal toxicity. The prophylactic use of intravenous saline fluids is also recommended with LAmB to reduce the risk of nephrotoxicity. In addition, magnesium and potassium supplementation should be considered to reduce the risk of hypomagnesaemia and hypokalaemia, respectively. Alternate dosing strategies, including intermittent dosing and, for certain fungal infections, single-dose high-dose induction therapy, may be useful in minimizing nephrotoxicity, but additional research is necessary.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Maertens J, Birne R, Felton T, et al. Liposomal amphotericin B and renal safety: review of the evidence and clinical considerations. J Antimicrob Chemother. 2026. PMID: 41549663. doi:10.1093/jac/dkaf473

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。